In a filing, Nurix Therapeutics Inc revealed its Chief Legal Officer Ring Christine unloaded Company’s shares for reported $0.14 million on Nov 01 ’24. In the deal valued at $24.28 per share,5,760 shares were sold. As a result of this transaction, Ring Christine now holds 28,084 shares worth roughly $0.69 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, van Houte Hans sold 3,546 shares, generating $86,083 in total proceeds. Upon selling the shares at $24.28, the Chief Financial Officer now owns 33,724 shares.
Before that, JOHANNES VAN HOUTE bought 3,546 shares. Nurix Therapeutics Inc shares valued at $87,161 were divested by the Officer at a price of $24.58 per share.
UBS initiated its Nurix Therapeutics Inc [NRIX] rating to a Buy in a research note published on October 24, 2024; the price target was $35. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Truist started covering the stock on July 31, 2024. It rated NRIX as “a Buy”.
Price Performance Review of NRIX
On Friday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock fall -0.45% to $24.47. Over the last five days, the stock has lost -6.85%. Nurix Therapeutics Inc shares have risen nearly 137.11% since the year began. Nevertheless, the stocks have risen 332.33% over the past one year. While a 52-week high of $27.60 was reached on 10/28/24, a 52-week low of $4.96 was recorded on 01/29/24. SMA at 50 days reached $24.20, while 200 days put it at $17.75.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 24.02, which if violated will result in even more drops to 23.56. On the upside, there is a resistance level at 24.84. A further resistance level may holdings at 25.21. The Relative Strength Index (RSI) on the 14-day chart is 50.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.53%. Stochastics %K at 27.19% indicates the stock is a holding.
How much short interest is there in Nurix Therapeutics Inc?
A steep rise in short interest was recorded in Nurix Therapeutics Inc stocks on 2024-10-15, dropping by -0.12 million shares to a total of 9.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 9.36 million shares. There was a decline of -1.34%, which implies that there is a negative sentiment for the stock.
